🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Relapsed and Refractory Acute Myeloid Leukemia (RR-AML)

Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia NCT04716452Phase 11 site📍 Charlottesville Keystone Nano, Inc · Tests: Ceramide NanoLiposome (Ceraxa) Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA. NCT06328179NA1 site📍 Huai'an Huai'an First People's Hospital · Tests: Venetoclax 100 mg d1，200 mg d2，400 mg d3-14； Administration of Anti Tim-3/CD123 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML) NCT06125652Phase 1, Phase 21 site📍 Xuzhou Xuzhou Medical University · Tests: anti Tim-3/CD123 CAR-T cell therapy HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia NCT07137637Phase 11 site📍 Tianjin Hangzhou Polymed Biopharmaceuticals, Inc. · Tests: HPB-092 tablet
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy